Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 19 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

8Total
Not Applicable (3)
P 1 (5)

Trial Status

Recruiting9
Not Yet Recruiting6
Unknown2
Enrolling By Invitation1
Active Not Recruiting1

Clinical Trials (19)

Showing 19 of 19 trials
NCT07137338Phase 1RecruitingPrimary

A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy

NCT07486752Not Yet RecruitingPrimary

BAG3-DCM Natural History Study

NCT07426419Phase 1Not Yet RecruitingPrimary

An AAV Gene Therapy Trial of AFTX-201 in Adults With BAG3-Associated Dilated Cardiomyopathy (DCM)

NCT07420907Recruiting

Study of the Progression of Chronic Cardiovascular Conditions

NCT06902896Phase 1Active Not RecruitingPrimary

Safety and Efficacy of FAP iCDC in End-stage Dilated Cardiomyopathy

NCT07359690Recruiting

Multimodal Analysis of Endomyocardial Biopsies

NCT07354646Recruiting

The Application of T1 Mapping in Real-World

NCT07345338Not ApplicableNot Yet Recruiting

Mainstreaming Genetic Testing for Non-Ischemic Cardiomyopathy in Western Canada

NCT02413450Enrolling By Invitation

Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac Arrhythmias

NCT07347197Phase 1Not Yet Recruiting

Endocardial Delivery for Myocardial Regeneration Using Allogeneic iPSC-derived Cardiomyocyte Spheroids for HF With Systolic Dysfunction (EMERALD Study)

NCT07293338RecruitingPrimary

Prognostic Values of Coronary Microvascular Dysfunction in Patients With Dilated Cardiomyopathy

NCT07145138Recruiting

UIC Multi-Ethnic DCM Registry

NCT06922851Not ApplicableRecruitingPrimary

Protein A Immunoadsorption in Dilated Cardiomyopathy (RPIA-DCM)

NCT06741995RecruitingPrimary

Evaluating the Prognostic Impact of Anti-β1AR Antibodies and Anti-L-CaC Antibodies in Patients With Dilated Cardiomyopathy

NCT06794710Not ApplicableNot Yet Recruiting

Early Identification and Treatment of Rare Cardiomyopathy Cohorts

NCT06748261Not Yet Recruiting

AI-enabled Screening and Diagnosis of Cardiomyopathies Using Coronary CTA

NCT06607471Recruiting

Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study.

NCT02293603Phase 1UnknownPrimary

Dilated cardiomYopathy iNtervention With Allogeneic MyocardIally-regenerative Cells (DYNAMIC)

NCT00523653UnknownPrimary

The Genetics of Dilated Cardiomyopathy: A Quebec-Based Study

Showing all 19 trials

Research Network

Activity Timeline